Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cassava Sciences Inc
(NQ:
SAVA
)
26.97
+0.04 (+0.15%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Sep 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Why Cassava Sciences Stock Soared Today
June 21, 2021
Investors applauded the company's update on its clinical programs.
Via
The Motley Fool
Why Cassava Sciences Shares Are Moving Today
June 21, 2021
Cassava Sciences Inc (NASDAQ:SAVA) shares are trading high...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 21, 2021
Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a...
Via
Benzinga
Cassava Sciences Stock Gains After Outlining Clinical Development Progress For Lead Alzheimer's Candidate
June 21, 2021
Cassava Sciences Inc (NASDAQ: SAVA) has announced a mid-year update highlighting clinical development progress and providing guidance on upcoming data releases for...
Via
Benzinga
These 2 Biotech Stocks Are Up 1,000% This Year
June 16, 2021
New approaches to treating Alzheimer's could mean even bigger gains in the future.
Via
The Motley Fool
Why Anavex Stock Nearly Round-Tripped Its Double-Digit Gain This Week
June 15, 2021
Researchers featured a pair of Anavex Life Sciences drugs in a paper on Alzheimer's disease this week, but AVXL stock plunged on Tuesday.
Via
Investor's Business Daily
Where Will Biogen Be in 1 Year?
June 15, 2021
The controversy never ends with this biotech's new Alzheimer's drug.
Via
The Motley Fool
Exposures
Product Safety
Tuesday Talk: Action!
June 15, 2021
U.S. stock markets started the week in continued action mode. The S&P 500 closed at 4,255, up nearly 8 points, the Dow closed at 34,394, down 85 points and the Nasdaq Composite closed at 14,174, up...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Biotechs Ready To Roar
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
Exposures
Product Safety
46 Stocks Moving In Friday's Mid-Day Session
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
8 Health Care Stocks Showing Unusual Options Activity In Today's Session
June 11, 2021
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
June 11, 2021
Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...
Via
Benzinga
Ignore Biogen: 3 Reasons These Stocks Will Be Better Alzheimer's Investments
June 11, 2021
Data doesn't lie. These companies have the potential to quickly steal the spotlight.
Via
The Motley Fool
Exposures
Product Safety
Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use?
June 08, 2021
Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.
Via
Investor's Business Daily
Why Centene Stock Was Up 19% in May
June 07, 2021
New executives and confirmation that an acquisition will close soon sparked a rally in the shares.
Via
The Motley Fool
Why Cassava Sciences Was Up 15% in May
June 07, 2021
Thanks to key funding, its Alzheimer's drug is on track even after Biogen's historic approval.
Via
The Motley Fool
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
June 07, 2021
There are better options for investors looking to profit from potential Alzheimer's disease treatments.
Via
The Motley Fool
Exposures
Product Safety
Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab
June 07, 2021
The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.
Via
Investor's Business Daily
Exposures
Product Safety
Annovis Bio Stock Rockets As Alzheimer's Drug Tops Biogen, Cassava Sciences
May 21, 2021
Annovis Bio said Friday its experimental Alzheimer's and Parkinson's treatment improved cognition in less than a month, leading ANVS stock to soar.
Via
Investor's Business Daily
The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks
May 21, 2021
The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too.
Via
Investor's Business Daily
Exposures
Product Safety
Caladrius Biosciences, Cassava Sciences Secure Non-Dilutive Funding For Product Development
May 12, 2021
Caladrius Biosciences Inc (NASDAQ: CLBS) has received $1.4 million in non-dilutive funding as an approved participant of the Technology Business Tax...
Via
Benzinga
Biden's Budget May Boost These 3 Biotechs
May 10, 2021
It signals a big push toward curing a neurological disease with a massive market.
Via
The Motley Fool
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021
April 27, 2021
Upgrades According to JP Morgan, the prior rating for BP Midstream Partners LP (NYSE:BPMP) was changed from Neutral to Overweight. For the fourth quarter, BP Midstream...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 27, 2021
Gainers Aldeyra Therapeutics (NASDAQ:ALDX) stock moved upwards by 25.29% to $13.92 during Tuesday's pre-market session. The company's market cap stands at $661.8...
Via
Benzinga
Alzheimer's Disease: 5 Stocks on Biotech Radars
April 22, 2021
What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other...
Via
Talk Markets
48 Biggest Movers From Yesterday
April 22, 2021
Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Netflix Shares Slide
April 21, 2021
Toward the end of trading Wednesday, the Dow traded up 0.75% to 34,073.66 while the NASDAQ rose 0.70% to 13,882.45. The S&P also rose, gaining 0.64% to 4,161.25. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Welbilt Surges Following Acquisition News; Unique Fabricating Shares Plummet
April 21, 2021
Midway through trading Wednesday, the Dow traded up 0.62% to 34,029.67 while the NASDAQ rose 0.31% to 13,829.69. The S&P also rose, gaining 0.43% to 4,152.82. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.